Home » Newsletters » BioWorld

BioWorld

Sep. 20, 2001

View Archived Issues

Bayer, Millennium Restructure Part Of Deal; Identify 140 Targets

BMS Paying Cancer Drug Costs In Landmark $2B ImClone Deal

Amgen Drops Praecis Plenaxis, Guilfords Neuroimmunophilins

Glaxo Scientists Enlist KO Mice To Elucidate Role Of Glutamate Receptor In Drug Dependence

Gilead Eyeing NDA Filing After Releasing Phase III HBV Data

Other News To Note